Latest Breaking News On - Diamedica therapeutics daily - Page 1 : comparemela.com

DiaMedica Therapeutics (DMAC) to Release Earnings on Wednesday

DiaMedica Therapeutics (DMAC) to Release Earnings on Wednesday
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Craig hallumDiamedica therapeutics company profileDiamedica therapeutics incDiamedica therapeuticsGet free reportMedica therapeuticsMedica therapeutics incDiamedica therapeutics daily

DiaMedica Therapeutics (DMAC) Set to Announce Earnings on Wednesday

DiaMedica Therapeutics (NASDAQ:DMAC – Get Free Report) will be issuing its quarterly earnings data after the market closes on Wednesday, May 8th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link. DiaMedica Therapeutics (NASDAQ:DMAC […]

Craig hallumDiamedica therapeutics incDiamedica therapeuticsGet free reportMedica therapeuticsMedica therapeutics incDiamedica therapeutics dailyNasdaq dmac

Craig Hallum Begins Coverage on DiaMedica Therapeutics (NASDAQ:DMAC)

Craig Hallum Begins Coverage on DiaMedica Therapeutics (NASDAQ:DMAC)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Craig hallumStonebridge capital advisorsDiamedica therapeutics incParagon associates ii joint ventureAvantax advisory services incDiamedica therapeuticsFree reportMedica therapeuticsGet free reportCapital advisorsParagon associatesAvantax advisory servicesMedica therapeutics incDiamedica therapeutics daily

Craig Hallum Lowers DiaMedica Therapeutics (NASDAQ:DMAC) Price Target to $8 00

DiaMedica Therapeutics (NASDAQ:DMAC – Free Report) had its target price trimmed by Craig Hallum from $11.00 to $8.00 in a research note published on Thursday morning, Benzinga reports. The firm currently has a buy rating on the stock. Separately, Oppenheimer reiterated an outperform rating and issued a $6.00 price objective (down previously from $7.00) on […]

Craig hallumAvantax advisory services incCitadel advisorsStonebridge capital advisorsDiamedica therapeutics incDiamedica therapeuticsFree reportMedica therapeuticsGet free reportStreet groupAdvisory servicesMedica therapeutics incDiamedica therapeutics daily

DiaMedica Therapeutics (NASDAQ:DMAC) Trading Up 0 7%

Shares of DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Get Free Report) were up 0.7% during mid-day trading on Thursday . The company traded as high as $3.02 and last traded at $2.91. Approximately 44,769 shares traded hands during trading, a decline of 42% from the average daily volume of 77,022 shares. The stock had previously closed […]

Charles schwab investment management incDiamedica therapeutics incStonebridge capital advisorsRenaissance technologiesDiamedica therapeuticsGet free reportMedica therapeuticsSchwab investment managementCapital advisorsStreet groupMedica therapeutics incDiamedica therapeutics dailyNasdaq dmac